HUMAN IMMUNODEFICIENCY VIRUS 1 POSITIVE
Clinical trials for HUMAN IMMUNODEFICIENCY VIRUS 1 POSITIVE explained in plain language.
Never miss a new study
Get alerted when new HUMAN IMMUNODEFICIENCY VIRUS 1 POSITIVE trials appear
Sign up with your email to follow new studies for HUMAN IMMUNODEFICIENCY VIRUS 1 POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial targets cancer in HIV patients
Disease control CompletedThis study tested whether the drug pomalidomide could safely help control Kaposi sarcoma, a cancer that often affects people with HIV. It involved 26 HIV-positive adults in sub-Saharan Africa who took the drug daily in repeating cycles. Researchers measured how well the drug shra…
Matched conditions: HUMAN IMMUNODEFICIENCY VIRUS 1 POSITIVE
Phase: PHASE2 • Sponsor: AIDS Malignancy Consortium • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC
-
Small study asks: does cancer treatment help patients feel better?
Symptom relief CompletedThis small, completed pilot study aimed to understand how standard chemotherapy drugs affect the daily life and well-being of people with AIDS-related Kaposi sarcoma in Tanzania. Ten participants receiving treatment were followed to see if their quality of life improved. The main…
Matched conditions: HUMAN IMMUNODEFICIENCY VIRUS 1 POSITIVE
Sponsor: AIDS Malignancy Consortium • Aim: Symptom relief
Last updated Mar 30, 2026 14:34 UTC